Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Bardet–Biedl syndrome and related disorders in Japan

Abstract

Bardet–Biedl syndrome (BBS) is a rare autosomal recessive disorder characterized by obesity, mental impairment, rod-cone dystrophy, polydactyly, male hypogonadism, and renal abnormalities. This disorder is caused by mutations in BBS1-21. Alström syndrome (AS), caused solely by mutations in ALMS1, is another genetic obesity syndrome clinically similar to BBS. We previously conducted the first nationwide survey of BBS in Japan and found four patients with genetically definite BBS. In this study, exome analyses were performed on new patients whose symptoms fulfilled the diagnostic criteria for BBS. We identified one reported heterozygous mutation in BBS1 (p.R429*) in one patient, two novel mutations (p.L493R and p.H719Y) in BBS20 in a second patient, and one novel mutation (p.Q920*) and one reported mutation (p.R2928*) in ALMS1 in a third patient, who was subsequently diagnosed with AS. The first patient with BBS was previously considered to have digenic heterozygous mutations in BBS1 and BBS4. RT-PCR and long-range genomic PCR analyses identified a new heterozygous mutation in BBS1, the deletion of exons 10 and 11. Thus, this patient was compound heterozygous for mutations in BBS1. Many studies have described digenic heterozygous mutations in BBS. However, undetected mutations might have existed in either one of the mutated genes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Nakamura F, Sasaki H, Kajihara H, Yamanoue M. Laurence-Moon-Biedl syndrome accompanied by congenital hepatic fibrosis. J Gastroenterol Hepatol. 1990;5:206–10.

    Article  CAS  Google Scholar 

  2. Yamada K, Miura M, Miyayama H, Sakashita N, Kochi M, Ushio Y. Diffuse brainstem glioma in a patient with Laurence-Moon-(Bardet-)Biedl syndrome. Pediatr Neurosurg. 2000;33:323–7.

    Article  CAS  Google Scholar 

  3. Tonomura Y, Hirano M, Shimada K, Asai H, Ikeda M, Kataoka H, et al. Treatable fluctuating mental impairment in a patient with Bardet-Biedl syndrome. Clin Neurol Neurosurg. 2009;111:102–4.

    Article  Google Scholar 

  4. Hirano M, Ohishi M, Yamashita T, Ikuno Y, Iwahashi H, Mano T, et al. Abnormal cystatin C levels in two patients with Bardet-Biedl syndrome. Clin Med Insights Case Rep. 2011;4:17–20.

    Article  Google Scholar 

  5. Saida K, Inaba Y, Hirano M, Satake W, Toda T, Suzuki Y, et al. A case of Bardet-Biedl syndrome complicated with intracranial hypertension in a Japanese child. Brain Dev. 2014;36:721–24.

    Article  Google Scholar 

  6. Hirano M, Satake W, Ihara K, Tsuge I, Kondo S, Saida K, et al. The first nationwide survey and genetic analyses of Bardet-Biedl syndrome in Japan. PLoS ONE. 2015;10:e0136317.

    Article  CAS  Google Scholar 

  7. Ohto T, Enokizono T, Tanaka R, Tanaka M, Suzuki H, Sakai A, et al. A novel BBS10 mutation identified in a patient with Bardet-Biedl syndrome with a violent emotional outbreak. Hum Genome Var. 2017;4:17033.

    Article  CAS  Google Scholar 

  8. Kurata K, Hosono K, Hikoya A, Kato A, Saitsu H, Minoshima S, et al. Clinical characteristics of a Japanese patient with Bardet-Biedl syndrome caused by BBS10 mutations. Jpn J Ophthalmol. 2018;62:458–66.

    Article  CAS  Google Scholar 

  9. Sato S, Morimoto T, Hotta K, Fujikado T, Nishida K. A novel compound heterozygous mutation in TTC8 identified in a Japanese patient. Hum Genome Var. 2019;6:14.

    Article  Google Scholar 

  10. Fauser S, Munz M, Besch D. Further support for digenic inheritance in Bardet-Biedl syndrome. J Med Genet. 2003;40:e104.

    Article  CAS  Google Scholar 

  11. Gazzo A, Raimondi D, Daneels D, Moreau Y, Smits G, Van Dooren S, et al. Understanding mutational effects in digenic diseases. Nucleic Acids Res. 2017;45:e140.

    Article  CAS  Google Scholar 

  12. Beales PL, Elcioglu N, Woolf AS, Parker D, Flinter FA. New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J Med Genet. 1999;36:437–46.

    PubMed  PubMed Central  CAS  Google Scholar 

  13. Examination Committee of Criteria for ‘Obesity Disease’ in Japan, Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J. 2002;66:987–92.

    Article  Google Scholar 

  14. Isojima T, Kato N, Ito Y, Kanzaki S, Murata M. Growth standard charts for Japanese children with mean and standard deviation (SD) values based on the year 2000 national survey. Clin Pediatr Endocrinol. 2016;25:71–6.

    Article  Google Scholar 

  15. Hirano M, Samukawa M, Isono C, Saigoh K, Nakamura Y, Kusunoki S. Noncoding repeat expansions for ALS in Japan are associated with the ATXN8OS gene. Neurol Genet. 2018;4:e252.

    Article  CAS  Google Scholar 

  16. Beales PL, Badano JL, Ross AJ, Ansley SJ, Hoskins BE, Kirsten B, et al. Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome. Am J Hum Genet. 2003;72:1187–99.

    Article  CAS  Google Scholar 

  17. Schaefer E, Stoetzel C, Scheidecker S, Geoffroy V, Prasad MK, Redin C, et al. Identification of a novel mutation confirms the implication of IFT172 (BBS20) in Bardet-Biedl syndrome. J Hum Genet. 2016;61:447–50.

    Article  CAS  Google Scholar 

  18. Katoh Y, Nozaki S, Hartanto D, Miyano R, Nakayama K. Architectures of multisubunit complexes revealed by a visible immunoprecipitation assay using fluorescent fusion proteins. J Cell Sci. 2015;128:2351–62.

    Article  CAS  Google Scholar 

  19. Mourao A, Nager AR, Nachury MV, Lorentzen E. Structural basis for membrane targeting of the BBSome by ARL6. Nat Struct Mol Biol. 2014;21:1035–41.

    Article  CAS  Google Scholar 

  20. Kim JC, Badano JL, Sibold S, Esmail MA, Hill J, Hoskins BE, et al. The Bardet-Biedl protein BBS4 targets cargo to the pericentriolar region and is required for microtubule anchoring and cell cycle progression. Nat Genet. 2004;36:462–70.

    Article  CAS  Google Scholar 

  21. Asai H, Hirano M, Kiriyama T, Ikeda M, Ueno S. Naturally- and experimentally-designed restorations of the Parkin gene deficit in autosomal recessive juvenile parkinsonism. Biochem Biophys Res Commun. 2010;391:800–5.

    Article  CAS  Google Scholar 

  22. Lindstrand A, Frangakis S, Carvalho CM, Richardson EB, McFadden KA, Willer JR, et al. Copy-number variation contributes to the mutational load of Bardet-Biedl syndrome. Am J Hum Genet. 2016;99:318–36.

    Article  CAS  Google Scholar 

  23. Miao H, Zhou J, Yang Q, Liang F, Wang D, Ma N, et al. Long-read sequencing identified a causal structural variant in an exome-negative case and enabled preimplantation genetic diagnosis. Hereditas. 2018;155:32.

    Article  Google Scholar 

  24. Aliferis K, Helle S, Gyapay G, Duchatelet S, Stoetzel C, Mandel JL, et al. Differentiating Alstrom from Bardet-Biedl syndrome (BBS) using systematic ciliopathy genes sequencing. Ophthalmic Genet. 2012;33:18–22.

    Article  CAS  Google Scholar 

  25. Rahmouni K, Fath MA, Seo S, Thedens DR, Berry CJ, Weiss R, et al. Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. J Clin Invest. 2008;118:1458–67.

    Article  CAS  Google Scholar 

  26. Heydet D, Chen LX, Larter CZ, Inglis C, Silverman MA, Farrell GC, et al. A truncating mutation of Alms1 reduces the number of hypothalamic neuronal cilia in obese mice. Dev Neurobiol. 2013;73:1–13.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Design or conceptualization of the study: MH, WS, and TT. Analysis or interpretation of the data: MH, WS, NM, KS, YS, and PCC. Drafting or revising the manuscript for intellectual content: MH, WS, SK, and TT.

Corresponding author

Correspondence to Makito Hirano.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hirano, M., Satake, W., Moriyama, N. et al. Bardet–Biedl syndrome and related disorders in Japan. J Hum Genet 65, 847–853 (2020). https://doi.org/10.1038/s10038-020-0778-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-020-0778-y

This article is cited by

Search

Quick links